iRobot 2010 Annual Report Download - page 8

Download and view the complete annual report

Please find page 8 of the 2010 iRobot annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 132

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132

(3) FMR LLC and Edward C. Johnson 3d each have sole dispositive power with respect to all of the shares.
Fidelity Management & Research Company (“Fidelity”), a wholly owned subsidiary of FMR LLC and an
investment adviser, is a beneficial owner of all of the shares, 1,615,286 of which are attributable to
Fidelity OTC Portfolio, an investment company registered under the Investment Company Act of 1940.
Neither FMR LLC nor Edward C. Johnson 3d has the sole power to vote or direct the voting of the
shares owned directly by the Fidelity Funds, which power resides with the Funds’ Boards of Trustees.
Fidelity carries out the voting of the shares under written guidelines established by the Funds’ Boards of
Trustees. The address of each reporting entity is 82 Devonshire Street, Boston, MA 02109. This informa-
tion has been obtained from a Schedule 13G filed by FMR LLC and Edward C. Johnson 3d with the
Securities and Exchange Commission on February 14, 2011.
(4) OppenheimerFunds, Inc. has shared voting power and shared dispositive power with respect to all of
these shares. This information has been obtained from a Schedule 13G/A filed by OppenheimerFunds,
Inc. with the Securities and Exchange Commission on February 10, 2011, and includes 1,500,600 shares
over which Oppenheimer Global Opportunity Fund has shared voting and shared dispositive power. The
address of Oppenheimer Global Opportunity Fund is 6803 S. Tucson Way, Centennial, CO 80112.
(5) Includes 110,850 shares issuable to Mr. Angle upon exercise of stock options and 7,563 shares issuable
to Mr. Angle upon vesting of restricted stock units.
(6) Includes 95,448 shares issuable to Mr. Leahy upon exercise of stock options and 3,088 shares issuable to
Mr. Leahy upon vesting of restricted stock units.
(7) Includes 99,616 shares issuable to Mr. Dyer upon exercise of stock options, 2,925 shares issuable to
Mr. Dyer upon vesting of restricted stock units and 100 shares owned by Mr. Dyer’s stepson. Mr. Dyer
disclaims beneficial ownership of the 100 shares owned by his stepson, except to the extent of his pecuni-
ary interest, if any.
(8) Includes 14,750 shares issuable to Mr. Beck upon exercise of stock options and 10,175 shares issuable to
Mr. Beck upon vesting of restricted stock units.
(9) Includes 29,925 shares issuable to Mr. Moses upon exercise of stock options and 988 shares issuable to
Mr. Moses upon vesting of restricted stock units.
(10) Includes 39,029 shares issuable to Ms. Dean upon exercise of stock options and 725 shares issuable to
Ms. Dean upon vesting of restricted stock units.
(11) Includes 99,740 shares issuable to Mr. Weinstein upon exercise of stock options and 1,575 shares issuable
to Mr. Weinstein upon vesting of restricted stock units.
(12) Includes 19,333 shares issuable to Dr. Brooks upon exercise of stock options.
(13) Includes an aggregate of 326,525 shares held by iD5 Fund, L.P. Dr. Chwang is a general partner of the
management company for iD5 Fund, L.P. and may be deemed to share voting and investment power with
respect to all shares held by iD5 Fund, L.P. Dr. Chwang disclaims beneficial ownership of such shares
except to the extent of his pecuniary interest, if any. Also includes 65,000 shares issuable to Dr. Chwang
upon exercise of stock options and 123,710 shares held in a trust for the benefit of certain of his family
members. As co-trustees of the family trust, Dr. Chwang shares voting and dispositive power over the
shares held by the trust with his spouse.
(14) Includes 80,000 shares issuable to Dr. Gansler upon exercise of stock options.
(15) Includes 80,000 shares issuable to Mr. Geisser upon exercise of stock options and 11,247 shares issuable
to Mr. Geisser upon termination of service.
(16) Includes 31,333 shares issuable to Ms. Greiner upon exercise of stock options and 228 shares issuable to
Ms. Greiner upon termination of service.
(17) Includes 80,000 shares issuable to Mr. McNamee upon exercise of stock options and 3,489 shares issu-
able to Mr. McNamee upon termination of service.
4